Therefore, RKIP/miR-450b-5p/NRF2/NQO1 axis has vital roles in regulation of radioresistance and serves as a promising therapy target for improving the efficacy of clinical treatment in NPC. Here, NQO1 is linked to nasopharyngeal carcinoma.